$AMIX News

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

Autonomix Medical Announces USPTO Issues U.S. Patent Titled Systems, Methods, And Devices For Monitoring And Treatment Of Tissues Within And/Or Through A Lumen Wall

Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

Autonomix Medical to Present at LSI USA ’26

Autonomix Medical Has Received A Notice Of Allowance For A U.S. Patent Titled "DEVICES, SYSTEMS, AND METHODS FOR DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDER".

Autonomix Medical Selected for Best Innovation Competition at CRT 2026

Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation

Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation

Autonomix Medical To Present New Long-Term Pain Mitigation Data In Pancreatic Cancer At SSO 2026 Annual Meeting

Autonomix Medical To Present New Long-Term Pain Mitigation Data In Pancreatic Cancer At SSO 2026 Annual Meeting

Autonomix Medical to Present Final Analysis on Pain Mitigation in Pancreatic Cancer at SIO 2026 Annual Scientific Meeting

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

Autonomix Medical Presents New Subgroup Clinical Data From PoC Study At 2026 ASCO GI Demonstrating Durable And Meaningful Pain Relief In Pancreatic Cancer Patients Across All Disease Stages

Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Autonomix Medical shares are trading higher after the European Patent Office granted the company Patent No. EP4230133 (the '133 patent), titled, "Controlled and Precise Treatment of Cardiac Tissues."

Autonomix Medical Secures New European Patent For Precision Cardiac Neuromodulation